Abstract

The Global Trigger tool (GTT) is considered one of the most reliable methods in evaluating adverse events (AEs). This study aimed to evaluate the feasibility and potential of the GTT to identify AEs in clinical applications. 240 patient records were randomly selected from the Obstetrics and Gynecology department of a university hospital. Patient files were retrospectively examined as 20 patient files per month in a two-year period. The records were reviewed using GTT an approach developed by the American Institute for Health Development (IHI). Percentage of hospitalizations with AEs 9,58, AEs per thousand patient days 47.81, and AEs per thousand patient hospitalizations 95.83 were found. By applying GTT, 45 cases in category E (Damage is temporary and requires intervention) and 35 cases in category F (Damage is temporary and requires hospitalization or prolonged hospitalization) were detected. CRP elevation (5/11), vaginal surgeries (3/15), and use of Dynoprostone (6/22), helped detect AEs in category E (3 cases) and category F (11 cases). GTT detected 8.3 times more AEs than VRS. The application of the GTT is feasible in Clinical practice and a reliable and effective instrument for detecting AEs when adapted to the departmental specifics. High CRP, vaginal surgeries, and the use of vaginal Dynoprostone could be used as a trigger.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.